Mcd Diffuse Large B Cell Lymphoma C4725002
A common aggressive lymphoma where large B cells grow rapidly, often in lymph nodes or organs. Typically affects adults. Usually responds to chemotherapy combined with immunotherapy.
Key facts at a glance
- ICD-10
- C83.37
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Facial swelling (SVC syndrome)
Chest pain
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Persistent cough
(respiratory)Dyspnea
(respiratory)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
R-CHOP Immunochemotherapy
Rituximab combined with CHOP chemotherapy is the standard first-line treatment for diffuse large B-cell lymphoma. The addition of rituximab has significantly improved outcomes compared to chemotherapy alone.
Consolidation Radiation Therapy
Involved-site radiation therapy may be added after chemotherapy for localized disease or residual masses. Modern techniques like IMRT allow precise targeting while sparing normal tissues.
Additional treatment options
Salvage Chemotherapy and Autologous Transplant
For relapsed disease, salvage chemotherapy regimens followed by high-dose therapy with stem cell rescue may offer potential cure. Response to salvage therapy predicts transplant outcomes.
procedureResponse Assessment and Surveillance
Regular imaging with PET-CT and clinical assessment evaluates treatment response. Surveillance imaging detects relapse in asymptomatic patients who may benefit from early intervention.
monitoringNutritional Support and Survivorship Care
Registered dietitian consultation addresses nutrition during and after treatment. Survivorship programs focus on managing long-term effects, preventing secondary malignancies, and promoting overall wellness.
lifestyleWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Mcd Diffuse Large B Cell Lymphoma C4725002?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Mcd Diffuse Large B Cell Lymphoma C4725002. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy